| 2025 |
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease |
Articolo in rivista |
Vai |
| 2025 |
Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders |
Articolo in rivista |
Vai |
| 2025 |
Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk |
Review essay (rassegna critica) |
Vai |
| 2025 |
Mediterranean diet and hypertension: relationship between adherence to a Mediterranean diet and arterial hypertension |
Articolo in rivista |
Vai |
| 2025 |
Genetic polymorphisms and cytokine levels in ischemic stroke: associations with subtypes and prognosis |
Articolo in rivista |
Vai |
| 2025 |
Identification of Novel Mutations in Patients Affected by Gaucher Disease |
Articolo in rivista |
Vai |
| 2024 |
Paraneoplastic Cerebellar Degeneration Associated with Breast Cancer: A Case Report and a Narrative Review |
Review essay (rassegna critica) |
Vai |
| 2024 |
Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides |
Articolo in rivista |
Vai |
| 2023 |
Vascular health in subjects with rheumatoid arthritis: assessment of endothelial function indices and serum biomarkers of vascular damage |
Articolo in rivista |
Vai |
| 2023 |
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction |
Articolo in rivista |
Vai |
| 2022 |
Molecular Mechanisms of Inflammasome in Ischemic
Stroke Pathogenesis |
Review essay (rassegna critica) |
Vai |
| 2021 |
Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure |
Articolo in rivista |
Vai |
| 2021 |
Pathogenesis and molecular mechanisms of anderson–fabry disease and possible new molecular addressed therapeutic strategies |
Review essay (rassegna critica) |
Vai |
| 2021 |
A case of infective colitis due to Yersinia enterocolitica complicated by microliver abscesses mimicking multiple liver occult metastases: a case report |
Articolo in rivista |
Vai |
| 2021 |
Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dysfunction indices and markers of adipo-inflammatory dysfunction |
Articolo in rivista |
Vai |
| 2021 |
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease |
Articolo in rivista |
Vai |
| 2021 |
Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial |
Articolo in rivista |
Vai |
| 2019 |
Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction |
Articolo in rivista |
Vai |
| 2019 |
Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities. |
Articolo in rivista |
Vai |
| 2018 |
Genetics and gene therapy of anderson-fabry disease |
Articolo in rivista |
Vai |
| 2017 |
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease. |
Articolo in rivista |
Vai |
| 2017 |
Education and hypertension: impact on global cardiovascular risk |
Articolo in rivista |
Vai |
| 2016 |
IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine. |
Articolo in rivista |
Vai |
| 2015 |
Association between low education and higher global cardiovascular risk |
Articolo in rivista |
Vai |
| 2015 |
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene |
Articolo in rivista |
Vai |
| 2015 |
Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk |
Articolo in rivista |
Vai |
| 2015 |
Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy |
Articolo in rivista |
Vai |
| 2014 |
Plasma adiponectin: A contributing factor for cardiac changes in
visceral obesity-associated hypertension |
Articolo in rivista |
Vai |
| 2014 |
May Adiponectin be considered as a Novel
Cardiometabolic Biomarker? |
Articolo in rivista |
Vai |
| 2013 |
Nutrizione,sovrappeso e sindrome metabolica |
Proceedings |
Vai |
| 2012 |
Iperuricemia: significato clinico e nuove prospettive di trattamento |
Proceedings |
Vai |
| 2012 |
Take the wind out your salis: relationship among energy drink abuse, hypertension, and break-up of cerebral aneurysm |
Articolo in rivista |
Vai |
| 2011 |
Il paziente iperteso ad alto rischio cadiovascolare |
Proceedings |
Vai |
| 2010 |
Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome. |
Articolo in rivista |
Vai |
| 2010 |
The Relationship between the Transforming Growth Factor β1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects |
Articolo in rivista |
Vai |
| 2009 |
Visceral obesity and metabolic syndrome: two faces of the same medal? |
Articolo in rivista |
Vai |
| 2008 |
Transforming growth factor β1 T29C gene polymorphism and hypertension: Relationship with cardiovascular and renal damage |
Articolo in rivista |
Vai |
| 2008 |
La terapia dietetica nell’insufficienza renale cronica. |
Monografia |
Vai |
| 2008 |
Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study. |
Articolo in rivista |
Vai |
| 2007 |
Obesità e rischio cardiovascolare. |
Articolo in rivista |
Vai |
| 2007 |
Effect of dual blockade of renin-angiotensin system on TGF beta 1 and left ventricular structure and function in hypertensive patients |
Articolo in rivista |
Vai |
| 2006 |
Sindrome metabolica: fatti e compromessi. |
Proceedings |
Vai |
| 2006 |
Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: a 24 week randomized controlled double-dummy trial. |
Articolo in rivista |
Vai |
| 2006 |
Obesity: a main factor of metabolic syndrome? |
Articolo in rivista |
Vai |
| 2006 |
Improving efficacy of PubMed Clinical Queries for retrieving scientifically strong studies on treatment. |
Articolo in rivista |
Vai |
| 2006 |
Sindrome Metabolica |
Articolo in rivista |
Vai |
| 2005 |
Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1. |
Articolo in rivista |
Vai |
| 2005 |
Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: A 24-week randomized controlled trial |
Articolo in rivista |
Vai |
| 2005 |
Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial |
Articolo in rivista |
Vai |
| 2005 |
L’obesità fattore o co-fattore di rischio? |
Altro |
Vai |
| 2005 |
Scompenso cardiaco da disfunzione diastolica. |
Articolo in rivista |
Vai |
| 2005 |
Effetti cardioprotettivi del Blocco del Sistema Renina-Angiotensina-Aldosterone tramite l’associazione ACE-inibitore – Sartani: Relazione con i livelli circolanti di Transforming Growth Factor ß1. |
Proceedings |
Vai |
| 2004 |
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 |
Proceedings |
Vai |
| 2004 |
Associazione tra elevate livelli circolanti di Transforming growth factor ß1 (TGF ß1) ed alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. |
Proceedings |
Vai |
| 2004 |
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRASFORMING GROWTH FACTOR BETA-1 |
Abstract in rivista |
Vai |
| 2004 |
Associazione tra elevati livelli circolanti di Transforming growth factor ß1 (TGF ß1) e alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. |
Proceedings |
Vai |
| 2004 |
Obesity and cardiovascular risk: the new public health problem of worldwide proportions. |
Articolo in rivista |
Vai |
| 2004 |
Transforming growth factor beta1 ed effetto nefroprotettivo dell’associazione ACE-inibitori-AT1 antagonista in soggetti ipertesi con iniziale danno renale |
Proceedings |
Vai |
| 2003 |
Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. |
Articolo in rivista |
Vai |
| 2003 |
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects |
Articolo in rivista |
Vai |
| 1998 |
Micro-albuminuria in obese subjects: relationship among body fat distribution, blood pressure and left ventricular structure and function. |
Articolo in rivista |
Vai |
| 1997 |
Prevalence of obesity and ischaemic
heart disease in hypertensive subjects |
Articolo in rivista |
Vai |
| 1995 |
Heredity and obesity-associated
hypertension: impact of hormonal characteristics and left ventricular mass. J
Hypertens |
Articolo in rivista |
Vai |
| 1995 |
Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide |
Articolo in rivista |
Vai |
| 1995 |
Hemostatic function in young subjects with central obesity: relationship with left ventricular function |
Articolo in rivista |
Vai |
